Literature DB >> 8546994

Increased lysophosphatidylcholine content in lesional psoriatic skin.

A K Ryborg1, B Grøn, K Kragballe.   

Abstract

Various cell stimuli occur via activation of phospholipase A2, which hydrolyses polyunsaturated fatty acids from the sn-2 position of membrane phospholipids, resulting in the formation of polyunsaturated fatty acids and lysophospholipids. The level of lysophospholipids is determined by the balance between phospholipase A2 activity and the rate of catabolism of the lysophospholipids. One of the lysophospholipid classes, lysophosphatidylcholine, has been shown to stimulate certain leucocyte activities which are of importance for the induction and maintenance of inflammation. In addition, it has been demonstrated that phospholipase A2 activity is increased in psoriatic skin. In the present study, we analysed the levels of lysophosphatidylcholine, by thin layer chromatography, in lesional psoriatic skin, uninvolved psoriatic skin and normal skin. The lysophosphatidylcholine content, expressed as mumol lysophosphatidylcholine/mumol phosphatidylcholine, was 1.55, 0.21 and 0.12% in lesional psoriatic skin, uninvolved psoriatic skin and normal skin, respectively. The level of lysophosphatidylcholine was significantly elevated in lesional compared with uninvolved psoriatic skin (P = 0.004) and normal skin (P = 0.002). The increased lysophosphatidylcholine levels in psoriatic skin indicate that the phospholipase A2 activation is not accompanied by a corresponding increase in the activity of enzymes catabolizing lysoPC. If present in biologically active concentrations, lysophosphatidylcholine may contribute to the induction and maintenance of the inflammatory and immunological processes occurring in lesional psoriatic skin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546994     DOI: 10.1111/j.1365-2133.1995.tb02667.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids.

Authors:  Jaewoo Choi; Wujuan Zhang; Xiaodong Gu; Xi Chen; Li Hong; James M Laird; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2010-10-25       Impact factor: 3.739

2.  Molecular cartography of the human skin surface in 3D.

Authors:  Amina Bouslimani; Carla Porto; Christopher M Rath; Mingxun Wang; Yurong Guo; Antonio Gonzalez; Donna Berg-Lyon; Gail Ackermann; Gitte Julie Moeller Christensen; Teruaki Nakatsuji; Lingjuan Zhang; Andrew W Borkowski; Michael J Meehan; Kathleen Dorrestein; Richard L Gallo; Nuno Bandeira; Rob Knight; Theodore Alexandrov; Pieter C Dorrestein
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

3.  Transplantation of human skin microbiota in models of atopic dermatitis.

Authors:  Ian A Myles; Kelli W Williams; Jensen D Reckhow; Momodou L Jammeh; Nathan B Pincus; Inka Sastalla; Danial Saleem; Kelly D Stone; Sandip K Datta
Journal:  JCI Insight       Date:  2016-07-07

4.  Antimicrobial effects of lysophosphatidylcholine on methicillin-resistant Staphylococcus aureus.

Authors:  Haruko Miyazaki; Naoko Midorikawa; Saki Fujimoto; Natsumi Miyoshi; Hideto Yoshida; Tetsuya Matsumoto
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

5.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

6.  Formation of transient non-protein calcium pores by lysophospholipids in S49 Lymphoma cells.

Authors:  H A Wilson-Ashworth; A M Judd; R M Law; B D Freestone; S Taylor; M K Mizukawa; K R Cromar; S Sudweeks; J D Bell
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

7.  Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

Authors:  A D Michel; E Fonfria
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

8.  Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation.

Authors:  Wenbo Li; Wei Zhang; Meihong Deng; Patricia Loughran; Yiting Tang; Hong Liao; Xianying Zhang; Jian Liu; Timothy R Billiar; Ben Lu
Journal:  Shock       Date:  2018-09       Impact factor: 3.454

9.  Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine.

Authors:  Yong Chen; Zi-Long Wang; Michele Yeo; Qiao-Juan Zhang; Ana E López-Romero; Hui-Ping Ding; Xin Zhang; Qian Zeng; Sara L Morales-Lázaro; Carlene Moore; Ying-Ai Jin; Huang-He Yang; Johannes Morstein; Andrey Bortsov; Marcin Krawczyk; Frank Lammert; Manal Abdelmalek; Anna Mae Diehl; Piotr Milkiewicz; Andreas E Kremer; Jennifer Y Zhang; Andrea Nackley; Tony E Reeves; Mei-Chuan Ko; Ru-Rong Ji; Tamara Rosenbaum; Wolfgang Liedtke
Journal:  Gastroenterology       Date:  2021-04-02       Impact factor: 33.883

10.  Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation.

Authors:  Alan Brito Carneiro; Bruna Maria Ferreira Iaciura; Lilian Lie Nohara; Carla Duque Lopes; Esteban Mauricio Cordero Veas; Vania Sammartino Mariano; Patricia Torres Bozza; Ulisses Gazos Lopes; Georgia Correa Atella; Igor Correia Almeida; Mário Alberto Cardoso Silva-Neto
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.